Related Experiment Video
Updated: Jul 9, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatment
1AstraZeneca R&D, Loughborough, UK. noel.snell@astrazeneca.com
Abstract:
The human respiratory tract is exposed to a constantly changing environment which may bring it into contact with a variety of pathogenic organisms. A range of innate and acquired defence mechanisms have evolved to counter these threats. Several new classes of therapeutic agent which may interfere with these defence mechanisms have recently been marketed or are under clinical development; this paper reviews some key examples, with the potential implications for disease management.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Respiratory Syncytial Virus Disease
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Humoral Immune Responses
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Microbiota of the Respiratory Tract

